Detemir potential applications in the treatment of diabetes during pregnancy: proven benefits and perspectives
In recent years there is notable growing prevalence of gestational and overt diabetes in pregnant women while rate of obstetric complications, neonatal morbidity, perinatal mortality in women with diabetes is maintained at the high level as compared with common population. Furhermore no doubt that f...
Guardado en:
Autores principales: | Lyudmila A. Ruyatkina, Maksim Y. Sorokin |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/57a08367b1984eb0ad169b8f3b5b3762 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Combined insulin detemir and liraglutide therapy in type 2 diabetic patients: a base for an alliance
por: Lyudmila Alexandrovna Ruyatkina, et al.
Publicado: (2017) -
Insulin therapy during pregnancy in women with type 1 diabetes
por: V V Potin, et al.
Publicado: (2009) -
Topical problems of diabetes treatment during pregnancy
por: Irina Yur'evna Demidova, et al.
Publicado: (2009) -
Early insulin therapy Coordination Council
por: Marina Vladimirovna Shestakova
Publicado: (2012) -
Basal insulin therapy in patients with type 2 diabetes mellitus and poor control of glycemia by oral hypoglycemic agents: results of direct comparative study of insulin analogs Lantus and Levemir
por: Alsu Gafurovna Zalevskaya, et al.
Publicado: (2010)